Key ligand–receptor pairs (ANXA1–FPR1 and APP–CD74) that drive these interactions regulate the phenotypes of tumor-associated macrophages (TAMs), which are functionally linked to the TME (82, 83). Here, CD74 is linked to neoplasm.